DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
NSDVX
Price
$25.69
Change
-$0.14 (-0.54%)
Updated
Jul 31 closing price
Net Assets
104.24M
Interact to see
Advertisement

DFSVX vs NSDVX

DFSVX vs NSDVX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. NSDVX commentary
Aug 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and NSDVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. NSDVX (104M). NSDVX pays higher dividends than DFSVX: NSDVX (2.32) vs DFSVX (1.50). DFSVX was incepted earlier than NSDVX: DFSVX (33 years) vs NSDVX (13 years). NSDVX (1.44) is less costly to investors than DFSVX (0.31). NSDVX is a more actively managed with annual turnover of: 14.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than NSDVX: DFSVX (0) vs NSDVX (5000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. NSDVX (25.87). DFSVX return over 5 years is better than : 50.66 vs. NSDVX (19.32).
DFSVXNSDVXDFSVX / NSDVX
Total Expense Ratio0.311.4422%
Annual Report Gross Expense Ratio0.311.4422%
Fund Existence33 years13 years-
Gain YTD21.33622.07897%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B104M18,750%
Annual Yield % from dividends1.502.3265%
Returns for 1 year34.3925.87133%
Returns for 3 years50.3728.95174%
Returns for 5 years50.6619.32262%
Returns for 10 years107.7163.34170%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I